Folate status of gut microbiome affects lifespan by unknown
Aging in Caenorhabditis elegans - nature versus 
nuture (or a diet of E. coli)?
The first genes extending lifespan were identified in the 
nematode Caenorhabditis elegans [1], and several of the 
metabolic pathways they are involved in are conserved in 
other species, including flies, mice and humans. Some of 
the pioneering studies on aging in C. elegans made use of 
RNA interference (RNAi) to manipulate gene expression, 
a strategy that is easily applied in C.  elegans by feeding 
the worms on Escherichia coli strains expressing the 
relevant RNA sequence.
However, it is becoming increasingly clear that the 
E. coli diet itself can have profound affects on C. elegans 
lifespan, and the degree of bacterial colonization within 
the worm gut has been shown to correlate inversely with 
worm lifespan [2]. In a recent paper in BMC Biology, Virk 
et al. [3] capitalize on a serendipitous finding - they show 
that a C. elegans lifespan extension phenotype originally 
attributed to an RNAi clone targeting the ugt-27 gene is 
actually due to a spontaneous mutation present in the 
host E. coli strain. The authors then use classic nutritional 
selection experiments and identify the mutation as an IS1 
insertion element within the E. coli aroD gene. AroD is a 
dehydratase required for the production of shikimate 
(SHK; Figure 1), which is in turn a precursor of choris-
mate, a precursor of a wide variety of aromatic com-
pounds in E.  coli. Thus, the aroD mutation affects pro-
duc tion of Phe, Tyr, and Trp (essential aromatic amino 
acids), menaquinol (vitamin K2), enterobactin (involved 
in E.  coli iron uptake), coenzyme Q (an essential lipid 
component of the respiratory chain) and folates (vitamin 
B9). Virk et al. convincingly demonstrate that the lifespan 
extension in C. elegans can be returned to normal when 
the diet of E. coli aroD- is supplemented with either SHK 
or the folate precursor, pABA (Figure 1), but not when it 
is supplemented with the other aromatic products of this 
pathway. Because pABA supplementation abrogates the 
lifespan extension of C. elegans fed the aroD- E. coli diet, 
Virk et al. focus their attention on folate metabolism.
pABA and sulfa drugs - do they impact more than 
just folate metabolism?
In E.  coli and other microbes, pABA is a precursor of 
dihydrofolate (DHF; Figure  2). Folates play crucial roles 
in metabolism of amino acids, purines and pyrimidines. 
Reduction of DHF produces the active form of the 
vitamin, tetrahydrofolate (THF), which in turn is a versa-
tile one-carbon carrier that functions to donate and accept 
one carbon units at differing states of oxidation, including 
5-methyl-THF, 5,10-methylene THF, 5,10-methenyl-THF, 
and formyl-THF. These folate coenzymes play essential 
roles in the synthesis of nucleic acids and amino acid 
metabolism. Because folates also contain variable numbers 
of glutamate residues, cells contain a truly bewildering 
array of mono- and poly-glutamated folate derivatives. 
Formyl-THF-Glu3 is the most abundant species in E. coli, 
and the authors show its content is severely decreased in 
the E.  coli aroD mutant. Furthermore, they show that 
sulfa methoxazole (SMX), a sulfa-drug antibiotic and 
well-known pABA mimic, elicits a dose-dependent life-
span extension when added to C. elegans growth medium 
containing the standard laboratory E. coli OP50 diet. The 
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authors show that formyl-THF-Glu3 content is also 
dramatically decreased in SMX-treated OP50 E. coli, and 
in C. elegans fed the SMX-treated OP50 E. coli diet.
The results show that inhibition of folate synthesis in 
the microbe extends C.  elegans lifespan. Is a decreased 
supply of folate per se mediating lifespan extension? Virk 
et al. tested whether the direct addition of folate to the 
aroD E.  coli diet reversed C.  elegans lifespan extension. 
At the outset, this seemed like a straightforward experi-
ment: E. coli (and other microbes) do not assimilate exo-
genous folates (this is why the sulfa drugs are so effective). 
However, the results obtained showed intermediate 
effects. Folate supplementation only partially reversed 
the lifespan extension. In fact, the authors showed that 
this folate supplementation experiment is not so simple. 
When the E. coli aroD mutant was grown in the presence 
of exogenous folate the formyl-THF-Glu3 content of the 
bacteria increased! While microbial folate catabolism 
pathways are not completely understood, it is clear that 
E. coli has a transporter that allows for uptake of pABA-
glutamate, a folate breakdown product (Figure 2), and a 
hydrolase that can process pABA-glu into free pABA and 
Figure 1. E. coli aroD mutants have defects in shikimate biosynthesis and fail to produce diverse aromatic metabolites. An abbreviated 
sequence of reactions involved in the E. coli biosynthesis of shikimate (SHK) and chorismate, and the products of this metabolism, are indicated. 
Black solid arrows indicate one step; black dashed arrows indicate multi-step pathways (four gene products catalyzing three steps convert SHK 
to chorismate). Chorismate is a precursor in the synthesis of aromatic amino acids (Phe, Tyr, Trp), menaquinol (used in E. coli respiratory electron 
transport and a precursor of vitamin K), enterobactin (a siderophore used by E. coli to acquire iron), 4-hydroxybenzoic acid (4-HB; a precursor of 
coenzyme Q) and para-aminobenzoic acid (pABA; a precursor of folate). Addition of either SHK or pABA reversed the lifespan extension in C. elegans 
fed a diet of aroD mutant E. coli (green boxes). In contrast, addition of the aromatic amino acids or 4-HB failed to reverse the lifespan extension 
(red dashed boxes). pABA also serves as a precursor of coenzyme Q in the yeast Saccharomyces cerevisiae [6]. However, it is not yet know whether 
pABA is an aromatic ring precursor in coenzyme Q biosynthesis in E. coli (red dashed arrow with question marks). Sulfa drugs mimic pABA and 
hence inhibit folate biosynthesis in microbes, but the effect on coenzyme Q has yet to be determined.
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glutamate [4]. Hence, the catabolism of exogenously 
added folate by E.  coli (and by the gut microbiome) 
leads to de novo synthesis of more folate. Finally, the 
extent to which C. elegans takes up exogenously added 
folate was not determined, although this may have 
important implications for whether folate supple men-
tation is an effective way to boost folate stores in 
C. elegans.
Figure 2. Sulfa drugs strike more than once in the folate biosynthetic pathway. Dihydropteroate synthase catalyzes the condensation of 
dihydropterin pyrophosphate and pABA to form dihydropteroate. Glutamate chain length depends on the cellular role of the folate derivative, 
and the nal tetrahydrofolate product may have from one to six Glu residues. As indicated by the red lines, sulfa drugs (such as sulfamethoxazole, 
SMX) block folate production at the dihydropteroate synthase step by competing with pABA, and by acting as a substrate itself. The resulting 
sulfa-DHP derivative is an additional folate biosynthesis inhibitor, competing against dihydrofolate (DHF) for reduction by dihydrofolate reductase. 
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So the jury is still out - clearly the microbe’s folate 
status affects C. elegans lifespan. But whether this is due 
to the content of folate in the diet, or to indirect effects of 
the folate status on E.  coli or C.  elegans is still an open 
question. It would be interesting to test folate supple-
men tation with axenic medium, where E.  coli is elimi-
nated from the C.  elegans diet and the folate content 
could be precisely defined [5]. It would also be important 
to determine whether the enhanced lifespan of C. elegans 
fed either the E. coli aroD mutant, or OP50 treated with 
SMX, is related to the extent of bacterial colonization of 
the worm intestine [3].
It is intriguing to consider other possible fates of pABA 
in this model, as addition of pABA did completely reverse 
the lifespan extension in C. elegans fed the aroD- diet. In 
the yeast Saccharomyces cerevisiae, pABA serves as an 
alternative aromatic ring precursor in the biosynthesis of 
coenzyme Q [6]. The fate of pABA as a ring precursor of 
coenzyme Q in E.  coli or C.  elegans is still uncertain. 
Hence, it would be of interest to monitor the effect of 4-
HB or pABA supplementation on the coenzyme Q 
content in E. coli aroD mutants. Virk et al. showed that 
addition of 4-HB, an established ring precursor of co-
enzyme Q in E.  coli, did not reverse the lifespan exten-
sion. Nonetheless, since C. elegans fed respiratory defec-
tive mutant strains of E.  coli diet show an extended 
lifespan [7], the possible impact of SMX and pABA on 
coenzyme Q content and respiratory metabolism in 
E. coli remains an intriguing avenue of future investi gation.
Not only do sulfa drugs directly inhibit folate 
biosynthesis through competition of SMX with pABA at 
the dihydropteroate synthase step, but they also produce 
sulfa-dihydropteroate in the process, and this in turn acts 
as an inhibitor of dihydrofolate reductase (DHFR), the 
final step in the production of THF [8]. Although sulfa-
dihydropteroate is excreted by E.  coli, it is likely to be 
present in the worm gut. This raises the question of 
whether other drugs (such as methotrexate, an inhibitor 
of dihydrofolate reductase and widely used in chemo-
therapy) might also impart lifespan extension effects 
when added to the worm diet.
Folate supplementation, sulfa drugs, and human 
aging
Like C. elegans, mammals are unable to synthesize folate 
and acquire the metabolite through diet and gut micro-
flora production. Since 1998, the US Food and Drug 
Administration has required folate supplementation in 
all cereal grains, which has resulted in higher blood folate 
content of the adult, non-supplement using population 
[9]. Recently, a study on the gut microflora of 531 human 
subjects across a wide range of ages, ethnicities, and 
geography showed that microbes residing in babies are 
enriched in genes involved in de novo folate biosynthesis, 
whereas the microbes residing in adult subjects were 
enriched in genes that metabolize dietary folate and THF 
[10]. However, because folate supplementation regula-
tions and diet differ in the sampling population, there is 
insufficient data to assess whether the changes in micro-
bial folate biosynthesis gene expression are linked to 
dietary folate. Interestingly, Virk et al. note that sulfa 
drugs have been reported to inhibit microbiome folate 
synthesis and extend lifespan in rats [1]. While the 
mechanism remains to be determined regarding how 
genetic or pharmacological knockdown of folate in E. coli 
can enhance C.  elegans lifespan, Virk et al. have raised 
the intriguing possibility that manipulation of the folate 
status of gut microflora may impact lifespan in other 
species.
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